WASHINGTON EXAMINER.COM: Here’s a well-written article on the current US debate about how much a life is worth – more specifically, how much the government Medicare scheme and health insurers pay out for cancer drugs that prolong life for a few months. READ MORE>
Archive for the ‘Provenge’ Category
Prostate drug debate: What’s it worth to stay alive a few more months?
Posted in Provenge, Treatment debate, tagged cancer drugs, health insurers, life is worth, Medicare, prolong life, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment debate, Provenge treatment, US debate, WASHINGTON EXAMINER.COM on September 28, 2010| 2 Comments »
Provenge approval expected to rejuvenate cancer vaccine industry
Posted in Provenge, tagged advanced prostate cancer, cancer research, cancer vaccine industry, catherise, catheter, catheterisation, Dendreon, MARKETWIRE, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment, URO TODAY on September 12, 2010| Leave a Comment »
MARKETWIRE: The approval of Dendreon’s prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity. READ MORE>
Jury still out on how long immuno-therapeutic drugs like Provenge can prolong life
Posted in Provenge, tagged advanced prostate cancer, cancer research, catheter, immuno-therapy, KANSASCITY.COM, large clinical trials, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, vaccines on August 21, 2010| Leave a Comment »
KANSASCITY.COM: Researchers can cite anecdotes of cancer patients given months to live who have survived 15 years or longer after receiving vaccines, but so far conclusive evidence from large clinical trials is scant. READ MORE>
Prostate cancer drug Provenge finally starts earning money for its maker
Posted in Provenge, tagged advanced prostate cancer, catheter, Dendreon, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, WALL ST JOURNAL on August 6, 2010| Leave a Comment »
WALL ST JOURNAL: New wonder drug for treating advanced prostate cancer, Provenge, is finally making money for its manufacturer, Dendreon Corp. READ MORE>
Since the $93,000 treatment was launched at the beginning of May, doctors have written 500 prescriptions for the treatment, the company disclosed.
Provenge extends prostate patients’ lives about four months – at a cost of $130,000
Posted in Provenge, tagged ABC NEWS, advanced prostate cancer, cancer research, catheter, Dendreon, extending life, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment on July 31, 2010| Leave a Comment »
ABC NEWS: The new US wonder drug for treating advanced prostate cancer – Provenge – extends life about four months – at a cost of $NZ130,000 ($US93,000).
The makers say it took 15 years to develop, at a cost of $US1.2 billion. READ MORE> and MORE>
New Provenge treatment for advanced prostate cancer faces another hurdle
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, catheter, Centers for Medicare and Medicaid Services, Dendreon company, expensive immunotherapy treatment for prostate cancer, private insurers, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment debate, Provenge treatment, WALL ST JOURNAL on July 4, 2010| Leave a Comment »
WALL ST JOURNAL: The US government says it will begin analysis on whether the Dendreon company’s expensive immunotherapy treatment for prostate cancer – Provenge – is “reasonable and necessary.” READ MORE> (you need to subscribe)
The answer to that debate – the latest hurdle in Dendreon’s push to get Provenge used – will affect sales of the costly treatment.
If the Centers for Medicare and Medicaid Services covers it, that would increase the number of patients eligible and likely prompt private insurers to do the same. A denial by CMS could severely stifle the product’s growth.
Year-long wait for Provenge in US hospitals
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, BLOOMBERG, catheter, Dendreon Corp, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment on June 29, 2010| Leave a Comment »
BLOOMBERG: Prostate cancer patients seeking Dendreon Corp’s new tumour-fighting vaccine, Provenge, face delays of a year or more as hospital waiting lists dwarf the company’s capacity to produce medicine. READ MORE>
Provenge treatment for advanced prostate cancer showing few side effects
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment, provenge safe, Provenge treatment, side effects, US NEWS AND WORLD REPORT on June 3, 2010| Leave a Comment »
US NEWS AND WORLD REPORT: The newly approved therapeutic prostate cancer vaccine, Provenge, is safe and has few side effects, a new study finds. READ MORE>
Provenge – what the FDA approval means for men with advanced prostate cancer
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge treatment, side effects, US Prostate Cancer Foundation on May 29, 2010| Leave a Comment »
US PROSTATE CANCER FOUNDATION: Provenge appears to extend survival in men with advanced prostate cancer, and it does so without the serious side effects associated with chemotherapy, radiation and hormone therapy. READ MORE>
FDA approves Provenge – a breakthrough for men with advanced prostate cancer
Posted in PROSTATE CANCER, Provenge, tagged advanced prostate cancer, catheter, FDA, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment on May 6, 2010| 1 Comment »
PROSTABLOG NZ: At last – the FDA has approved Provenge, the new and highly promising treatment for men with advanced prostate cancer. READ MORE>